nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.256	1	CrCrCtD
Nortriptyline—ORM1—Erlotinib—pancreatic cancer	0.0605	0.126	CbGbCtD
Nortriptyline—CYP2E1—Dacarbazine—pancreatic cancer	0.0389	0.0811	CbGbCtD
Nortriptyline—CYP2E1—Tamoxifen—pancreatic cancer	0.0309	0.0646	CbGbCtD
Nortriptyline—ALB—Erlotinib—pancreatic cancer	0.0254	0.0531	CbGbCtD
Nortriptyline—CYP3A5—Tamoxifen—pancreatic cancer	0.024	0.0502	CbGbCtD
Nortriptyline—ALB—Irinotecan—pancreatic cancer	0.023	0.0479	CbGbCtD
Nortriptyline—CYP1A2—Dacarbazine—pancreatic cancer	0.0225	0.0469	CbGbCtD
Nortriptyline—ALB—Fluorouracil—pancreatic cancer	0.022	0.046	CbGbCtD
Nortriptyline—CYP3A5—Erlotinib—pancreatic cancer	0.0204	0.0427	CbGbCtD
Nortriptyline—CYP2C19—Tamoxifen—pancreatic cancer	0.0194	0.0405	CbGbCtD
Nortriptyline—CYP3A5—Irinotecan—pancreatic cancer	0.0185	0.0385	CbGbCtD
Nortriptyline—CYP1A2—Tamoxifen—pancreatic cancer	0.0179	0.0373	CbGbCtD
Nortriptyline—CYP2C9—Tamoxifen—pancreatic cancer	0.0161	0.0336	CbGbCtD
Nortriptyline—CYP1A2—Erlotinib—pancreatic cancer	0.0152	0.0317	CbGbCtD
Nortriptyline—CYP2D6—Tamoxifen—pancreatic cancer	0.0147	0.0308	CbGbCtD
Nortriptyline—CYP3A5—Docetaxel—pancreatic cancer	0.0135	0.0282	CbGbCtD
Nortriptyline—CYP3A5—Sunitinib—pancreatic cancer	0.0135	0.0281	CbGbCtD
Nortriptyline—CYP1A2—Fluorouracil—pancreatic cancer	0.0132	0.0275	CbGbCtD
Nortriptyline—CYP2D6—Erlotinib—pancreatic cancer	0.0125	0.0262	CbGbCtD
Nortriptyline—CYP2C9—Fluorouracil—pancreatic cancer	0.0119	0.0248	CbGbCtD
Nortriptyline—CYP3A4—Tamoxifen—pancreatic cancer	0.00937	0.0196	CbGbCtD
Nortriptyline—CYP3A4—Erlotinib—pancreatic cancer	0.00797	0.0166	CbGbCtD
Nortriptyline—CYP3A4—Irinotecan—pancreatic cancer	0.0072	0.015	CbGbCtD
Nortriptyline—CYP2D6—Doxorubicin—pancreatic cancer	0.00618	0.0129	CbGbCtD
Nortriptyline—CYP3A4—Docetaxel—pancreatic cancer	0.00528	0.011	CbGbCtD
Nortriptyline—CYP3A4—Sunitinib—pancreatic cancer	0.00525	0.011	CbGbCtD
Nortriptyline—CYP3A4—Doxorubicin—pancreatic cancer	0.00393	0.0082	CbGbCtD
Nortriptyline—ORM1—bile—pancreatic cancer	0.00141	0.303	CbGeAlD
Nortriptyline—HTR2A—enteric nervous system—pancreatic cancer	0.00121	0.26	CbGeAlD
Nortriptyline—ORM1—gall bladder—pancreatic cancer	0.000391	0.0842	CbGeAlD
Nortriptyline—ALB—gall bladder—pancreatic cancer	0.000343	0.0738	CbGeAlD
Nortriptyline—Anorexia—Gemcitabine—pancreatic cancer	0.000209	0.00142	CcSEcCtD
Nortriptyline—Dizziness—Erlotinib—pancreatic cancer	0.000208	0.00142	CcSEcCtD
Nortriptyline—Anorexia—Fluorouracil—pancreatic cancer	0.000205	0.0014	CcSEcCtD
Nortriptyline—Purpura—Doxorubicin—pancreatic cancer	0.000205	0.00139	CcSEcCtD
Nortriptyline—Hypotension—Gemcitabine—pancreatic cancer	0.000204	0.00139	CcSEcCtD
Nortriptyline—Eye disorder—Docetaxel—pancreatic cancer	0.000204	0.00139	CcSEcCtD
Nortriptyline—Insomnia—Irinotecan—pancreatic cancer	0.000203	0.00139	CcSEcCtD
Nortriptyline—Flushing—Docetaxel—pancreatic cancer	0.000203	0.00138	CcSEcCtD
Nortriptyline—Vomiting—Tamoxifen—pancreatic cancer	0.000202	0.00138	CcSEcCtD
Nortriptyline—Paraesthesia—Irinotecan—pancreatic cancer	0.000202	0.00138	CcSEcCtD
Nortriptyline—Cerebrovascular accident—Doxorubicin—pancreatic cancer	0.000201	0.00137	CcSEcCtD
Nortriptyline—Hypotension—Fluorouracil—pancreatic cancer	0.000201	0.00137	CcSEcCtD
Nortriptyline—Hypersensitivity—Sunitinib—pancreatic cancer	0.000201	0.00137	CcSEcCtD
Nortriptyline—Rash—Tamoxifen—pancreatic cancer	0.000201	0.00137	CcSEcCtD
Nortriptyline—Dermatitis—Tamoxifen—pancreatic cancer	0.000201	0.00137	CcSEcCtD
Nortriptyline—Ataxia—Epirubicin—pancreatic cancer	0.0002	0.00137	CcSEcCtD
Nortriptyline—Vomiting—Erlotinib—pancreatic cancer	0.0002	0.00137	CcSEcCtD
Nortriptyline—Somnolence—Irinotecan—pancreatic cancer	0.0002	0.00136	CcSEcCtD
Nortriptyline—Headache—Tamoxifen—pancreatic cancer	0.000199	0.00136	CcSEcCtD
Nortriptyline—Rash—Erlotinib—pancreatic cancer	0.000199	0.00135	CcSEcCtD
Nortriptyline—Dermatitis—Erlotinib—pancreatic cancer	0.000198	0.00135	CcSEcCtD
Nortriptyline—Insomnia—Gemcitabine—pancreatic cancer	0.000198	0.00135	CcSEcCtD
Nortriptyline—Dyspepsia—Irinotecan—pancreatic cancer	0.000198	0.00135	CcSEcCtD
Nortriptyline—Headache—Erlotinib—pancreatic cancer	0.000197	0.00135	CcSEcCtD
Nortriptyline—Paraesthesia—Gemcitabine—pancreatic cancer	0.000196	0.00134	CcSEcCtD
Nortriptyline—Asthenia—Sunitinib—pancreatic cancer	0.000196	0.00133	CcSEcCtD
Nortriptyline—Decreased appetite—Irinotecan—pancreatic cancer	0.000195	0.00133	CcSEcCtD
Nortriptyline—Arrhythmia—Docetaxel—pancreatic cancer	0.000195	0.00133	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Epirubicin—pancreatic cancer	0.000195	0.00133	CcSEcCtD
Nortriptyline—Insomnia—Fluorouracil—pancreatic cancer	0.000195	0.00133	CcSEcCtD
Nortriptyline—Somnolence—Gemcitabine—pancreatic cancer	0.000194	0.00133	CcSEcCtD
Nortriptyline—Fatigue—Irinotecan—pancreatic cancer	0.000194	0.00132	CcSEcCtD
Nortriptyline—Paraesthesia—Fluorouracil—pancreatic cancer	0.000193	0.00132	CcSEcCtD
Nortriptyline—Alopecia—Docetaxel—pancreatic cancer	0.000193	0.00132	CcSEcCtD
Nortriptyline—Pruritus—Sunitinib—pancreatic cancer	0.000193	0.00132	CcSEcCtD
Nortriptyline—Constipation—Irinotecan—pancreatic cancer	0.000192	0.00131	CcSEcCtD
Nortriptyline—Somnolence—Fluorouracil—pancreatic cancer	0.000191	0.0013	CcSEcCtD
Nortriptyline—Decreased appetite—Gemcitabine—pancreatic cancer	0.00019	0.0013	CcSEcCtD
Nortriptyline—Dyspepsia—Fluorouracil—pancreatic cancer	0.000189	0.00129	CcSEcCtD
Nortriptyline—Nausea—Tamoxifen—pancreatic cancer	0.000189	0.00129	CcSEcCtD
Nortriptyline—Fatigue—Gemcitabine—pancreatic cancer	0.000189	0.00129	CcSEcCtD
Nortriptyline—Constipation—Gemcitabine—pancreatic cancer	0.000187	0.00128	CcSEcCtD
Nortriptyline—Nausea—Erlotinib—pancreatic cancer	0.000187	0.00128	CcSEcCtD
Nortriptyline—Decreased appetite—Fluorouracil—pancreatic cancer	0.000187	0.00128	CcSEcCtD
Nortriptyline—Diarrhoea—Sunitinib—pancreatic cancer	0.000187	0.00127	CcSEcCtD
Nortriptyline—Dysgeusia—Docetaxel—pancreatic cancer	0.000186	0.00127	CcSEcCtD
Nortriptyline—Ataxia—Doxorubicin—pancreatic cancer	0.000185	0.00126	CcSEcCtD
Nortriptyline—Feeling abnormal—Irinotecan—pancreatic cancer	0.000185	0.00126	CcSEcCtD
Nortriptyline—Eosinophilia—Epirubicin—pancreatic cancer	0.000182	0.00124	CcSEcCtD
Nortriptyline—Dizziness—Sunitinib—pancreatic cancer	0.00018	0.00123	CcSEcCtD
Nortriptyline—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00018	0.00123	CcSEcCtD
Nortriptyline—Orthostatic hypotension—Doxorubicin—pancreatic cancer	0.00018	0.00123	CcSEcCtD
Nortriptyline—Body temperature increased—Irinotecan—pancreatic cancer	0.000178	0.00121	CcSEcCtD
Nortriptyline—Abdominal pain—Irinotecan—pancreatic cancer	0.000178	0.00121	CcSEcCtD
Nortriptyline—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000177	0.00121	CcSEcCtD
Nortriptyline—Pancytopenia—Epirubicin—pancreatic cancer	0.000175	0.00119	CcSEcCtD
Nortriptyline—Vomiting—Sunitinib—pancreatic cancer	0.000173	0.00118	CcSEcCtD
Nortriptyline—Body temperature increased—Gemcitabine—pancreatic cancer	0.000173	0.00118	CcSEcCtD
Nortriptyline—Rash—Sunitinib—pancreatic cancer	0.000172	0.00117	CcSEcCtD
Nortriptyline—Dermatitis—Sunitinib—pancreatic cancer	0.000172	0.00117	CcSEcCtD
Nortriptyline—Urticaria—Fluorouracil—pancreatic cancer	0.000171	0.00117	CcSEcCtD
Nortriptyline—Headache—Sunitinib—pancreatic cancer	0.000171	0.00116	CcSEcCtD
Nortriptyline—Syncope—Docetaxel—pancreatic cancer	0.000171	0.00116	CcSEcCtD
Nortriptyline—Leukopenia—Docetaxel—pancreatic cancer	0.00017	0.00116	CcSEcCtD
Nortriptyline—Pollakiuria—Epirubicin—pancreatic cancer	0.00017	0.00116	CcSEcCtD
Nortriptyline—Body temperature increased—Fluorouracil—pancreatic cancer	0.00017	0.00116	CcSEcCtD
Nortriptyline—Eosinophilia—Doxorubicin—pancreatic cancer	0.000169	0.00115	CcSEcCtD
Nortriptyline—Palpitations—Docetaxel—pancreatic cancer	0.000168	0.00115	CcSEcCtD
Nortriptyline—Weight increased—Epirubicin—pancreatic cancer	0.000168	0.00114	CcSEcCtD
Nortriptyline—Loss of consciousness—Docetaxel—pancreatic cancer	0.000167	0.00114	CcSEcCtD
Nortriptyline—Weight decreased—Epirubicin—pancreatic cancer	0.000167	0.00114	CcSEcCtD
Nortriptyline—Hypersensitivity—Irinotecan—pancreatic cancer	0.000165	0.00113	CcSEcCtD
Nortriptyline—Convulsion—Docetaxel—pancreatic cancer	0.000165	0.00112	CcSEcCtD
Nortriptyline—Hypertension—Docetaxel—pancreatic cancer	0.000164	0.00112	CcSEcCtD
Nortriptyline—Drowsiness—Epirubicin—pancreatic cancer	0.000164	0.00112	CcSEcCtD
Nortriptyline—Nausea—Sunitinib—pancreatic cancer	0.000162	0.0011	CcSEcCtD
Nortriptyline—Pancytopenia—Doxorubicin—pancreatic cancer	0.000162	0.0011	CcSEcCtD
Nortriptyline—Asthenia—Irinotecan—pancreatic cancer	0.000161	0.0011	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000161	0.0011	CcSEcCtD
Nortriptyline—Jaundice—Epirubicin—pancreatic cancer	0.00016	0.00109	CcSEcCtD
Nortriptyline—Stomatitis—Epirubicin—pancreatic cancer	0.00016	0.00109	CcSEcCtD
Nortriptyline—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000158	0.00108	CcSEcCtD
Nortriptyline—Dry mouth—Docetaxel—pancreatic cancer	0.000158	0.00108	CcSEcCtD
Nortriptyline—Sweating—Epirubicin—pancreatic cancer	0.000157	0.00107	CcSEcCtD
Nortriptyline—Pollakiuria—Doxorubicin—pancreatic cancer	0.000157	0.00107	CcSEcCtD
Nortriptyline—Asthenia—Gemcitabine—pancreatic cancer	0.000157	0.00107	CcSEcCtD
Nortriptyline—Confusional state—Docetaxel—pancreatic cancer	0.000157	0.00107	CcSEcCtD
Nortriptyline—Oedema—Docetaxel—pancreatic cancer	0.000155	0.00106	CcSEcCtD
Nortriptyline—Weight increased—Doxorubicin—pancreatic cancer	0.000155	0.00106	CcSEcCtD
Nortriptyline—Pruritus—Gemcitabine—pancreatic cancer	0.000155	0.00106	CcSEcCtD
Nortriptyline—Weight decreased—Doxorubicin—pancreatic cancer	0.000154	0.00105	CcSEcCtD
Nortriptyline—Diarrhoea—Irinotecan—pancreatic cancer	0.000154	0.00105	CcSEcCtD
Nortriptyline—Agranulocytosis—Epirubicin—pancreatic cancer	0.000153	0.00104	CcSEcCtD
Nortriptyline—Shock—Docetaxel—pancreatic cancer	0.000153	0.00104	CcSEcCtD
Nortriptyline—Pruritus—Fluorouracil—pancreatic cancer	0.000152	0.00104	CcSEcCtD
Nortriptyline—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000152	0.00104	CcSEcCtD
Nortriptyline—Drowsiness—Doxorubicin—pancreatic cancer	0.000152	0.00104	CcSEcCtD
Nortriptyline—Tachycardia—Docetaxel—pancreatic cancer	0.000152	0.00103	CcSEcCtD
Nortriptyline—Diarrhoea—Gemcitabine—pancreatic cancer	0.00015	0.00102	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000149	0.00102	CcSEcCtD
Nortriptyline—Dizziness—Irinotecan—pancreatic cancer	0.000149	0.00101	CcSEcCtD
Nortriptyline—Jaundice—Doxorubicin—pancreatic cancer	0.000148	0.00101	CcSEcCtD
Nortriptyline—Stomatitis—Doxorubicin—pancreatic cancer	0.000148	0.00101	CcSEcCtD
Nortriptyline—Anorexia—Docetaxel—pancreatic cancer	0.000148	0.00101	CcSEcCtD
Nortriptyline—Hepatitis—Epirubicin—pancreatic cancer	0.000147	0.00101	CcSEcCtD
Nortriptyline—Diarrhoea—Fluorouracil—pancreatic cancer	0.000147	0.001	CcSEcCtD
Nortriptyline—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000147	0.001	CcSEcCtD
Nortriptyline—Sweating—Doxorubicin—pancreatic cancer	0.000146	0.000993	CcSEcCtD
Nortriptyline—Oedema peripheral—Epirubicin—pancreatic cancer	0.000145	0.00099	CcSEcCtD
Nortriptyline—Hypotension—Docetaxel—pancreatic cancer	0.000145	0.000989	CcSEcCtD
Nortriptyline—Vomiting—Irinotecan—pancreatic cancer	0.000143	0.000974	CcSEcCtD
Nortriptyline—CYP3A5—islet of Langerhans—pancreatic cancer	0.000143	0.0307	CbGeAlD
Nortriptyline—Dizziness—Fluorouracil—pancreatic cancer	0.000142	0.00097	CcSEcCtD
Nortriptyline—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000142	0.000967	CcSEcCtD
Nortriptyline—Rash—Irinotecan—pancreatic cancer	0.000142	0.000966	CcSEcCtD
Nortriptyline—Dermatitis—Irinotecan—pancreatic cancer	0.000141	0.000965	CcSEcCtD
Nortriptyline—Headache—Irinotecan—pancreatic cancer	0.000141	0.000959	CcSEcCtD
Nortriptyline—Insomnia—Docetaxel—pancreatic cancer	0.00014	0.000957	CcSEcCtD
Nortriptyline—Paraesthesia—Docetaxel—pancreatic cancer	0.000139	0.000951	CcSEcCtD
Nortriptyline—Vomiting—Gemcitabine—pancreatic cancer	0.000139	0.000948	CcSEcCtD
Nortriptyline—Somnolence—Docetaxel—pancreatic cancer	0.000138	0.000941	CcSEcCtD
Nortriptyline—Rash—Gemcitabine—pancreatic cancer	0.000138	0.000941	CcSEcCtD
Nortriptyline—Dermatitis—Gemcitabine—pancreatic cancer	0.000138	0.00094	CcSEcCtD
Nortriptyline—Eye disorder—Epirubicin—pancreatic cancer	0.000138	0.000939	CcSEcCtD
Nortriptyline—Tinnitus—Epirubicin—pancreatic cancer	0.000137	0.000937	CcSEcCtD
Nortriptyline—Headache—Gemcitabine—pancreatic cancer	0.000137	0.000935	CcSEcCtD
Nortriptyline—Flushing—Epirubicin—pancreatic cancer	0.000137	0.000933	CcSEcCtD
Nortriptyline—Vomiting—Fluorouracil—pancreatic cancer	0.000137	0.000933	CcSEcCtD
Nortriptyline—Dyspepsia—Docetaxel—pancreatic cancer	0.000137	0.000932	CcSEcCtD
Nortriptyline—Hepatitis—Doxorubicin—pancreatic cancer	0.000136	0.00093	CcSEcCtD
Nortriptyline—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000136	0.000925	CcSEcCtD
Nortriptyline—Rash—Fluorouracil—pancreatic cancer	0.000136	0.000925	CcSEcCtD
Nortriptyline—Dermatitis—Fluorouracil—pancreatic cancer	0.000136	0.000924	CcSEcCtD
Nortriptyline—Decreased appetite—Docetaxel—pancreatic cancer	0.000135	0.00092	CcSEcCtD
Nortriptyline—Headache—Fluorouracil—pancreatic cancer	0.000135	0.000919	CcSEcCtD
Nortriptyline—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000134	0.000916	CcSEcCtD
Nortriptyline—Fatigue—Docetaxel—pancreatic cancer	0.000134	0.000913	CcSEcCtD
Nortriptyline—Nausea—Irinotecan—pancreatic cancer	0.000133	0.00091	CcSEcCtD
Nortriptyline—Constipation—Docetaxel—pancreatic cancer	0.000133	0.000905	CcSEcCtD
Nortriptyline—Arrhythmia—Epirubicin—pancreatic cancer	0.000132	0.000898	CcSEcCtD
Nortriptyline—SLC6A4—digestive system—pancreatic cancer	0.000131	0.0282	CbGeAlD
Nortriptyline—Alopecia—Epirubicin—pancreatic cancer	0.00013	0.000888	CcSEcCtD
Nortriptyline—Nausea—Gemcitabine—pancreatic cancer	0.00013	0.000886	CcSEcCtD
Nortriptyline—Feeling abnormal—Docetaxel—pancreatic cancer	0.000128	0.000872	CcSEcCtD
Nortriptyline—Nausea—Fluorouracil—pancreatic cancer	0.000128	0.000871	CcSEcCtD
Nortriptyline—Eye disorder—Doxorubicin—pancreatic cancer	0.000127	0.000869	CcSEcCtD
Nortriptyline—Tinnitus—Doxorubicin—pancreatic cancer	0.000127	0.000867	CcSEcCtD
Nortriptyline—Flushing—Doxorubicin—pancreatic cancer	0.000127	0.000863	CcSEcCtD
Nortriptyline—Tension—Epirubicin—pancreatic cancer	0.000126	0.000859	CcSEcCtD
Nortriptyline—Dysgeusia—Epirubicin—pancreatic cancer	0.000126	0.000857	CcSEcCtD
Nortriptyline—Nervousness—Epirubicin—pancreatic cancer	0.000125	0.00085	CcSEcCtD
Nortriptyline—Body temperature increased—Docetaxel—pancreatic cancer	0.000123	0.000837	CcSEcCtD
Nortriptyline—Abdominal pain—Docetaxel—pancreatic cancer	0.000123	0.000837	CcSEcCtD
Nortriptyline—Arrhythmia—Doxorubicin—pancreatic cancer	0.000122	0.000831	CcSEcCtD
Nortriptyline—Vision blurred—Epirubicin—pancreatic cancer	0.000121	0.000825	CcSEcCtD
Nortriptyline—Alopecia—Doxorubicin—pancreatic cancer	0.000121	0.000822	CcSEcCtD
Nortriptyline—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000119	0.000812	CcSEcCtD
Nortriptyline—Agitation—Epirubicin—pancreatic cancer	0.000118	0.000804	CcSEcCtD
Nortriptyline—CHRM3—digestive system—pancreatic cancer	0.000117	0.0252	CbGeAlD
Nortriptyline—Tension—Doxorubicin—pancreatic cancer	0.000117	0.000794	CcSEcCtD
Nortriptyline—Dysgeusia—Doxorubicin—pancreatic cancer	0.000116	0.000793	CcSEcCtD
Nortriptyline—Malaise—Epirubicin—pancreatic cancer	0.000116	0.000789	CcSEcCtD
Nortriptyline—Nervousness—Doxorubicin—pancreatic cancer	0.000115	0.000786	CcSEcCtD
Nortriptyline—Syncope—Epirubicin—pancreatic cancer	0.000115	0.000785	CcSEcCtD
Nortriptyline—Leukopenia—Epirubicin—pancreatic cancer	0.000115	0.000783	CcSEcCtD
Nortriptyline—Hypersensitivity—Docetaxel—pancreatic cancer	0.000114	0.00078	CcSEcCtD
Nortriptyline—Palpitations—Epirubicin—pancreatic cancer	0.000113	0.000773	CcSEcCtD
Nortriptyline—Loss of consciousness—Epirubicin—pancreatic cancer	0.000113	0.000769	CcSEcCtD
Nortriptyline—Vision blurred—Doxorubicin—pancreatic cancer	0.000112	0.000763	CcSEcCtD
Nortriptyline—Asthenia—Docetaxel—pancreatic cancer	0.000111	0.00076	CcSEcCtD
Nortriptyline—Convulsion—Epirubicin—pancreatic cancer	0.000111	0.000758	CcSEcCtD
Nortriptyline—Hypertension—Epirubicin—pancreatic cancer	0.000111	0.000755	CcSEcCtD
Nortriptyline—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.00011	0.000751	CcSEcCtD
Nortriptyline—Pruritus—Docetaxel—pancreatic cancer	0.00011	0.000749	CcSEcCtD
Nortriptyline—Agitation—Doxorubicin—pancreatic cancer	0.000109	0.000744	CcSEcCtD
Nortriptyline—Anxiety—Epirubicin—pancreatic cancer	0.000109	0.000742	CcSEcCtD
Nortriptyline—CYP2C19—digestive system—pancreatic cancer	0.000109	0.0234	CbGeAlD
Nortriptyline—Discomfort—Epirubicin—pancreatic cancer	0.000108	0.000736	CcSEcCtD
Nortriptyline—Malaise—Doxorubicin—pancreatic cancer	0.000107	0.00073	CcSEcCtD
Nortriptyline—Dry mouth—Epirubicin—pancreatic cancer	0.000107	0.000728	CcSEcCtD
Nortriptyline—Syncope—Doxorubicin—pancreatic cancer	0.000106	0.000726	CcSEcCtD
Nortriptyline—Leukopenia—Doxorubicin—pancreatic cancer	0.000106	0.000725	CcSEcCtD
Nortriptyline—Diarrhoea—Docetaxel—pancreatic cancer	0.000106	0.000724	CcSEcCtD
Nortriptyline—Confusional state—Epirubicin—pancreatic cancer	0.000106	0.00072	CcSEcCtD
Nortriptyline—Palpitations—Doxorubicin—pancreatic cancer	0.000105	0.000715	CcSEcCtD
Nortriptyline—Oedema—Epirubicin—pancreatic cancer	0.000105	0.000714	CcSEcCtD
Nortriptyline—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000104	0.000712	CcSEcCtD
Nortriptyline—Shock—Epirubicin—pancreatic cancer	0.000103	0.000702	CcSEcCtD
Nortriptyline—Convulsion—Doxorubicin—pancreatic cancer	0.000103	0.000701	CcSEcCtD
Nortriptyline—Dizziness—Docetaxel—pancreatic cancer	0.000103	0.0007	CcSEcCtD
Nortriptyline—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000103	0.000699	CcSEcCtD
Nortriptyline—Hypertension—Doxorubicin—pancreatic cancer	0.000103	0.000699	CcSEcCtD
Nortriptyline—Tachycardia—Epirubicin—pancreatic cancer	0.000102	0.000697	CcSEcCtD
Nortriptyline—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000101	0.00069	CcSEcCtD
Nortriptyline—Anxiety—Doxorubicin—pancreatic cancer	0.000101	0.000687	CcSEcCtD
Nortriptyline—CYP3A5—pancreas—pancreatic cancer	0.0001	0.0216	CbGeAlD
Nortriptyline—Discomfort—Doxorubicin—pancreatic cancer	9.99e-05	0.000681	CcSEcCtD
Nortriptyline—Anorexia—Epirubicin—pancreatic cancer	9.98e-05	0.000681	CcSEcCtD
Nortriptyline—Dry mouth—Doxorubicin—pancreatic cancer	9.89e-05	0.000674	CcSEcCtD
Nortriptyline—Vomiting—Docetaxel—pancreatic cancer	9.87e-05	0.000673	CcSEcCtD
Nortriptyline—Rash—Docetaxel—pancreatic cancer	9.79e-05	0.000667	CcSEcCtD
Nortriptyline—Hypotension—Epirubicin—pancreatic cancer	9.79e-05	0.000667	CcSEcCtD
Nortriptyline—Dermatitis—Docetaxel—pancreatic cancer	9.78e-05	0.000667	CcSEcCtD
Nortriptyline—Confusional state—Doxorubicin—pancreatic cancer	9.77e-05	0.000666	CcSEcCtD
Nortriptyline—Headache—Docetaxel—pancreatic cancer	9.73e-05	0.000663	CcSEcCtD
Nortriptyline—Oedema—Doxorubicin—pancreatic cancer	9.69e-05	0.000661	CcSEcCtD
Nortriptyline—Shock—Doxorubicin—pancreatic cancer	9.53e-05	0.00065	CcSEcCtD
Nortriptyline—Thrombocytopenia—Doxorubicin—pancreatic cancer	9.49e-05	0.000647	CcSEcCtD
Nortriptyline—Insomnia—Epirubicin—pancreatic cancer	9.47e-05	0.000646	CcSEcCtD
Nortriptyline—Tachycardia—Doxorubicin—pancreatic cancer	9.46e-05	0.000645	CcSEcCtD
Nortriptyline—Paraesthesia—Epirubicin—pancreatic cancer	9.4e-05	0.000641	CcSEcCtD
Nortriptyline—Hyperhidrosis—Doxorubicin—pancreatic cancer	9.37e-05	0.000639	CcSEcCtD
Nortriptyline—Somnolence—Epirubicin—pancreatic cancer	9.31e-05	0.000635	CcSEcCtD
Nortriptyline—Anorexia—Doxorubicin—pancreatic cancer	9.24e-05	0.00063	CcSEcCtD
Nortriptyline—Nausea—Docetaxel—pancreatic cancer	9.22e-05	0.000629	CcSEcCtD
Nortriptyline—Dyspepsia—Epirubicin—pancreatic cancer	9.22e-05	0.000629	CcSEcCtD
Nortriptyline—Decreased appetite—Epirubicin—pancreatic cancer	9.1e-05	0.000621	CcSEcCtD
Nortriptyline—Hypotension—Doxorubicin—pancreatic cancer	9.05e-05	0.000617	CcSEcCtD
Nortriptyline—Fatigue—Epirubicin—pancreatic cancer	9.03e-05	0.000616	CcSEcCtD
Nortriptyline—Constipation—Epirubicin—pancreatic cancer	8.96e-05	0.000611	CcSEcCtD
Nortriptyline—CYP1A2—digestive system—pancreatic cancer	8.88e-05	0.0191	CbGeAlD
Nortriptyline—Insomnia—Doxorubicin—pancreatic cancer	8.76e-05	0.000598	CcSEcCtD
Nortriptyline—Paraesthesia—Doxorubicin—pancreatic cancer	8.7e-05	0.000593	CcSEcCtD
Nortriptyline—Feeling abnormal—Epirubicin—pancreatic cancer	8.63e-05	0.000588	CcSEcCtD
Nortriptyline—Somnolence—Doxorubicin—pancreatic cancer	8.61e-05	0.000587	CcSEcCtD
Nortriptyline—CYP3A5—digestive system—pancreatic cancer	8.56e-05	0.0184	CbGeAlD
Nortriptyline—Dyspepsia—Doxorubicin—pancreatic cancer	8.53e-05	0.000582	CcSEcCtD
Nortriptyline—CYP2C9—digestive system—pancreatic cancer	8.43e-05	0.0181	CbGeAlD
Nortriptyline—Decreased appetite—Doxorubicin—pancreatic cancer	8.42e-05	0.000574	CcSEcCtD
Nortriptyline—Fatigue—Doxorubicin—pancreatic cancer	8.35e-05	0.00057	CcSEcCtD
Nortriptyline—Urticaria—Epirubicin—pancreatic cancer	8.32e-05	0.000567	CcSEcCtD
Nortriptyline—HRH1—digestive system—pancreatic cancer	8.31e-05	0.0179	CbGeAlD
Nortriptyline—Constipation—Doxorubicin—pancreatic cancer	8.29e-05	0.000565	CcSEcCtD
Nortriptyline—Body temperature increased—Epirubicin—pancreatic cancer	8.28e-05	0.000564	CcSEcCtD
Nortriptyline—Abdominal pain—Epirubicin—pancreatic cancer	8.28e-05	0.000564	CcSEcCtD
Nortriptyline—CYP2E1—digestive system—pancreatic cancer	7.99e-05	0.0172	CbGeAlD
Nortriptyline—Feeling abnormal—Doxorubicin—pancreatic cancer	7.98e-05	0.000544	CcSEcCtD
Nortriptyline—Hypersensitivity—Epirubicin—pancreatic cancer	7.72e-05	0.000526	CcSEcCtD
Nortriptyline—Urticaria—Doxorubicin—pancreatic cancer	7.7e-05	0.000525	CcSEcCtD
Nortriptyline—PTGS1—digestive system—pancreatic cancer	7.69e-05	0.0166	CbGeAlD
Nortriptyline—Abdominal pain—Doxorubicin—pancreatic cancer	7.66e-05	0.000522	CcSEcCtD
Nortriptyline—Body temperature increased—Doxorubicin—pancreatic cancer	7.66e-05	0.000522	CcSEcCtD
Nortriptyline—Asthenia—Epirubicin—pancreatic cancer	7.51e-05	0.000512	CcSEcCtD
Nortriptyline—Pruritus—Epirubicin—pancreatic cancer	7.41e-05	0.000505	CcSEcCtD
Nortriptyline—Diarrhoea—Epirubicin—pancreatic cancer	7.17e-05	0.000489	CcSEcCtD
Nortriptyline—Hypersensitivity—Doxorubicin—pancreatic cancer	7.14e-05	0.000487	CcSEcCtD
Nortriptyline—Asthenia—Doxorubicin—pancreatic cancer	6.95e-05	0.000474	CcSEcCtD
Nortriptyline—HTR2A—digestive system—pancreatic cancer	6.94e-05	0.0149	CbGeAlD
Nortriptyline—Dizziness—Epirubicin—pancreatic cancer	6.92e-05	0.000472	CcSEcCtD
Nortriptyline—Pruritus—Doxorubicin—pancreatic cancer	6.86e-05	0.000467	CcSEcCtD
Nortriptyline—Vomiting—Epirubicin—pancreatic cancer	6.66e-05	0.000454	CcSEcCtD
Nortriptyline—Diarrhoea—Doxorubicin—pancreatic cancer	6.63e-05	0.000452	CcSEcCtD
Nortriptyline—Rash—Epirubicin—pancreatic cancer	6.6e-05	0.00045	CcSEcCtD
Nortriptyline—Dermatitis—Epirubicin—pancreatic cancer	6.6e-05	0.00045	CcSEcCtD
Nortriptyline—Headache—Epirubicin—pancreatic cancer	6.56e-05	0.000447	CcSEcCtD
Nortriptyline—CYP3A4—digestive system—pancreatic cancer	6.43e-05	0.0138	CbGeAlD
Nortriptyline—Dizziness—Doxorubicin—pancreatic cancer	6.41e-05	0.000437	CcSEcCtD
Nortriptyline—CYP2D6—digestive system—pancreatic cancer	6.32e-05	0.0136	CbGeAlD
Nortriptyline—Nausea—Epirubicin—pancreatic cancer	6.22e-05	0.000424	CcSEcCtD
Nortriptyline—Vomiting—Doxorubicin—pancreatic cancer	6.16e-05	0.00042	CcSEcCtD
Nortriptyline—Rash—Doxorubicin—pancreatic cancer	6.11e-05	0.000417	CcSEcCtD
Nortriptyline—Dermatitis—Doxorubicin—pancreatic cancer	6.1e-05	0.000416	CcSEcCtD
Nortriptyline—Headache—Doxorubicin—pancreatic cancer	6.07e-05	0.000414	CcSEcCtD
Nortriptyline—Nausea—Doxorubicin—pancreatic cancer	5.76e-05	0.000392	CcSEcCtD
Nortriptyline—CHRM3—Signaling by GPCR—HRAS—pancreatic cancer	4.03e-06	3.54e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CXCL8—pancreatic cancer	4.02e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AKT1—pancreatic cancer	4.02e-06	3.53e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CXCL8—pancreatic cancer	4.01e-06	3.52e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—HRAS—pancreatic cancer	3.99e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—KRAS—pancreatic cancer	3.99e-06	3.51e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—HRAS—pancreatic cancer	3.98e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—pancreatic cancer	3.98e-06	3.5e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EGFR—pancreatic cancer	3.97e-06	3.49e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AKT1—pancreatic cancer	3.96e-06	3.48e-05	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AKT1—pancreatic cancer	3.95e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SRC—pancreatic cancer	3.95e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	3.95e-06	3.47e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CG—pancreatic cancer	3.94e-06	3.46e-05	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AKT1—pancreatic cancer	3.93e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SRC—pancreatic cancer	3.93e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—pancreatic cancer	3.93e-06	3.45e-05	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AKT1—pancreatic cancer	3.92e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—pancreatic cancer	3.92e-06	3.44e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—pancreatic cancer	3.91e-06	3.43e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CG—pancreatic cancer	3.91e-06	3.43e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—pancreatic cancer	3.9e-06	3.42e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—pancreatic cancer	3.88e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AKT1—pancreatic cancer	3.88e-06	3.41e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CCND1—pancreatic cancer	3.88e-06	3.4e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AKT1—pancreatic cancer	3.87e-06	3.4e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—VEGFA—pancreatic cancer	3.85e-06	3.38e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—pancreatic cancer	3.85e-06	3.38e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CTNNB1—pancreatic cancer	3.84e-06	3.37e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—pancreatic cancer	3.84e-06	3.37e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—PIK3CA—pancreatic cancer	3.83e-06	3.36e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—VEGFA—pancreatic cancer	3.83e-06	3.36e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CCND1—pancreatic cancer	3.81e-06	3.35e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—STAT3—pancreatic cancer	3.81e-06	3.35e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CCND1—pancreatic cancer	3.81e-06	3.34e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PPARG—pancreatic cancer	3.8e-06	3.34e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NRAS—pancreatic cancer	3.8e-06	3.34e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CCND1—pancreatic cancer	3.79e-06	3.33e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—pancreatic cancer	3.79e-06	3.33e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NRAS—pancreatic cancer	3.78e-06	3.32e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CCND1—pancreatic cancer	3.78e-06	3.32e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CTNNB1—pancreatic cancer	3.78e-06	3.32e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PPARG—pancreatic cancer	3.77e-06	3.31e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	3.77e-06	3.31e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	3.77e-06	3.31e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SRC—pancreatic cancer	3.76e-06	3.31e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—pancreatic cancer	3.76e-06	3.31e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HRAS—pancreatic cancer	3.76e-06	3.3e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CTNNB1—pancreatic cancer	3.76e-06	3.3e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—KRAS—pancreatic cancer	3.75e-06	3.3e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CCND1—pancreatic cancer	3.74e-06	3.29e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CTNNB1—pancreatic cancer	3.74e-06	3.29e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PTEN—pancreatic cancer	3.74e-06	3.29e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CCND1—pancreatic cancer	3.73e-06	3.28e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CTNNB1—pancreatic cancer	3.71e-06	3.26e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—pancreatic cancer	3.71e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—pancreatic cancer	3.7e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—APOE—pancreatic cancer	3.7e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CTNNB1—pancreatic cancer	3.7e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—pancreatic cancer	3.69e-06	3.25e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—pancreatic cancer	3.68e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PTEN—pancreatic cancer	3.68e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PTEN—pancreatic cancer	3.68e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PTEN—pancreatic cancer	3.67e-06	3.23e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—pancreatic cancer	3.67e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PTEN—pancreatic cancer	3.67e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—PIK3CA—pancreatic cancer	3.67e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—VEGFA—pancreatic cancer	3.66e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PTEN—pancreatic cancer	3.66e-06	3.22e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CB—pancreatic cancer	3.66e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AKT1—pancreatic cancer	3.65e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PTEN—pancreatic cancer	3.65e-06	3.21e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—pancreatic cancer	3.64e-06	3.19e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—pancreatic cancer	3.63e-06	3.19e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—pancreatic cancer	3.63e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTGS2—pancreatic cancer	3.62e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NRAS—pancreatic cancer	3.62e-06	3.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PTEN—pancreatic cancer	3.61e-06	3.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PTEN—pancreatic cancer	3.6e-06	3.17e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AKT1—pancreatic cancer	3.59e-06	3.15e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	3.58e-06	3.15e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AKT1—pancreatic cancer	3.57e-06	3.14e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AKT1—pancreatic cancer	3.56e-06	3.13e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—pancreatic cancer	3.55e-06	3.12e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HRAS—pancreatic cancer	3.54e-06	3.11e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MYC—pancreatic cancer	3.54e-06	3.11e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—pancreatic cancer	3.53e-06	3.1e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AKT1—pancreatic cancer	3.53e-06	3.1e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MYC—pancreatic cancer	3.52e-06	3.09e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AKT1—pancreatic cancer	3.52e-06	3.09e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—pancreatic cancer	3.51e-06	3.09e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—TYMS—pancreatic cancer	3.51e-06	3.08e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.5e-06	3.08e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—PIK3CA—pancreatic cancer	3.47e-06	3.05e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SRC—pancreatic cancer	3.47e-06	3.05e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CD—pancreatic cancer	3.46e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—pancreatic cancer	3.46e-06	3.04e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—PIK3CA—pancreatic cancer	3.45e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—pancreatic cancer	3.45e-06	3.03e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CD—pancreatic cancer	3.43e-06	3.02e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SRC—pancreatic cancer	3.41e-06	3e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SRC—pancreatic cancer	3.41e-06	2.99e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SRC—pancreatic cancer	3.4e-06	2.98e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HRAS—pancreatic cancer	3.39e-06	2.98e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SRC—pancreatic cancer	3.38e-06	2.97e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—VEGFA—pancreatic cancer	3.38e-06	2.97e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MYC—pancreatic cancer	3.37e-06	2.96e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—pancreatic cancer	3.36e-06	2.95e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SRC—pancreatic cancer	3.35e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—pancreatic cancer	3.35e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SRC—pancreatic cancer	3.34e-06	2.94e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CG—pancreatic cancer	3.34e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NRAS—pancreatic cancer	3.34e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—pancreatic cancer	3.34e-06	2.93e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—VEGFA—pancreatic cancer	3.32e-06	2.92e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	3.32e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AKT1—pancreatic cancer	3.32e-06	2.91e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—VEGFA—pancreatic cancer	3.31e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—pancreatic cancer	3.3e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—VEGFA—pancreatic cancer	3.3e-06	2.9e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—pancreatic cancer	3.29e-06	2.89e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—pancreatic cancer	3.28e-06	2.89e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NRAS—pancreatic cancer	3.28e-06	2.88e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	3.28e-06	2.88e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NRAS—pancreatic cancer	3.28e-06	2.88e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—pancreatic cancer	3.27e-06	2.88e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—KRAS—pancreatic cancer	3.27e-06	2.87e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NRAS—pancreatic cancer	3.27e-06	2.87e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—VEGFA—pancreatic cancer	3.26e-06	2.87e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—pancreatic cancer	3.26e-06	2.87e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NRAS—pancreatic cancer	3.26e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—VEGFA—pancreatic cancer	3.26e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—KRAS—pancreatic cancer	3.25e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTGS2—pancreatic cancer	3.25e-06	2.86e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—pancreatic cancer	3.23e-06	2.84e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NRAS—pancreatic cancer	3.22e-06	2.83e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—pancreatic cancer	3.22e-06	2.83e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PPARG—pancreatic cancer	3.22e-06	2.83e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NRAS—pancreatic cancer	3.22e-06	2.82e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HRAS—pancreatic cancer	3.19e-06	2.8e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PTEN—pancreatic cancer	3.16e-06	2.78e-05	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKT1—pancreatic cancer	3.13e-06	2.75e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—KRAS—pancreatic cancer	3.12e-06	2.74e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MYC—pancreatic cancer	3.11e-06	2.73e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—pancreatic cancer	3.1e-06	2.72e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—PIK3CA—pancreatic cancer	3.08e-06	2.7e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MYC—pancreatic cancer	3.06e-06	2.69e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MYC—pancreatic cancer	3.05e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—pancreatic cancer	3.05e-06	2.68e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	3.04e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MYC—pancreatic cancer	3.04e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—pancreatic cancer	3.04e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—pancreatic cancer	3.04e-06	2.67e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MYC—pancreatic cancer	3.03e-06	2.66e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—pancreatic cancer	3.03e-06	2.66e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CB—pancreatic cancer	3.02e-06	2.65e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—PIK3CA—pancreatic cancer	3.01e-06	2.64e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MYC—pancreatic cancer	3e-06	2.64e-05	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKT1—pancreatic cancer	3e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—pancreatic cancer	3e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MYC—pancreatic cancer	3e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CB—pancreatic cancer	2.99e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTGS2—pancreatic cancer	2.99e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—pancreatic cancer	2.99e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—PIK3CA—pancreatic cancer	2.99e-06	2.63e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—pancreatic cancer	2.99e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—pancreatic cancer	2.99e-06	2.62e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—pancreatic cancer	2.98e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTGS2—pancreatic cancer	2.97e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—pancreatic cancer	2.97e-06	2.61e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—pancreatic cancer	2.94e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CD—pancreatic cancer	2.94e-06	2.58e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—pancreatic cancer	2.93e-06	2.57e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—pancreatic cancer	2.91e-06	2.55e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—pancreatic cancer	2.89e-06	2.54e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—KRAS—pancreatic cancer	2.87e-06	2.52e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—PIK3CA—pancreatic cancer	2.86e-06	2.51e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—APOE—pancreatic cancer	2.86e-06	2.51e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PTEN—pancreatic cancer	2.84e-06	2.49e-05	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AKT1—pancreatic cancer	2.84e-06	2.49e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—KRAS—pancreatic cancer	2.83e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—KRAS—pancreatic cancer	2.82e-06	2.48e-05	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKT1—pancreatic cancer	2.82e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—KRAS—pancreatic cancer	2.81e-06	2.47e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—KRAS—pancreatic cancer	2.8e-06	2.46e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HRAS—pancreatic cancer	2.78e-06	2.44e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—KRAS—pancreatic cancer	2.78e-06	2.44e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—pancreatic cancer	2.77e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—KRAS—pancreatic cancer	2.77e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HRAS—pancreatic cancer	2.77e-06	2.43e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HRAS—pancreatic cancer	2.65e-06	2.33e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—PIK3CA—pancreatic cancer	2.64e-06	2.32e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PTEN—pancreatic cancer	2.61e-06	2.29e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—PIK3CA—pancreatic cancer	2.6e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—PIK3CA—pancreatic cancer	2.59e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	2.59e-06	2.28e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—PIK3CA—pancreatic cancer	2.59e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PTEN—pancreatic cancer	2.59e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—PIK3CA—pancreatic cancer	2.58e-06	2.27e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	2.58e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—PIK3CA—pancreatic cancer	2.57e-06	2.26e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CB—pancreatic cancer	2.56e-06	2.25e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—pancreatic cancer	2.55e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—PIK3CA—pancreatic cancer	2.55e-06	2.24e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—PIK3CA—pancreatic cancer	2.54e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTGS2—pancreatic cancer	2.53e-06	2.23e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AKT1—pancreatic cancer	2.52e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—pancreatic cancer	2.51e-06	2.21e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—pancreatic cancer	2.51e-06	2.2e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—pancreatic cancer	2.5e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—pancreatic cancer	2.49e-06	2.19e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PPARG—pancreatic cancer	2.49e-06	2.18e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—pancreatic cancer	2.47e-06	2.17e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—pancreatic cancer	2.46e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKT1—pancreatic cancer	2.46e-06	2.16e-05	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKT1—pancreatic cancer	2.44e-06	2.15e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HRAS—pancreatic cancer	2.44e-06	2.14e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HRAS—pancreatic cancer	2.4e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HRAS—pancreatic cancer	2.4e-06	2.11e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HRAS—pancreatic cancer	2.39e-06	2.1e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HRAS—pancreatic cancer	2.38e-06	2.09e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HRAS—pancreatic cancer	2.36e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HRAS—pancreatic cancer	2.35e-06	2.07e-05	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKT1—pancreatic cancer	2.34e-06	2.05e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	2.27e-06	1.99e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—PIK3CA—pancreatic cancer	2.23e-06	1.96e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PTEN—pancreatic cancer	2.21e-06	1.94e-05	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKT1—pancreatic cancer	2.16e-06	1.89e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKT1—pancreatic cancer	2.12e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AKT1—pancreatic cancer	2.12e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKT1—pancreatic cancer	2.12e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AKT1—pancreatic cancer	2.12e-06	1.86e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKT1—pancreatic cancer	2.11e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKT1—pancreatic cancer	2.1e-06	1.85e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKT1—pancreatic cancer	2.08e-06	1.83e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKT1—pancreatic cancer	2.08e-06	1.82e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	2e-06	1.76e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.97e-06	1.73e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.96e-06	1.72e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—PIK3CA—pancreatic cancer	1.84e-06	1.62e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—PIK3CA—pancreatic cancer	1.83e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AKT1—pancreatic cancer	1.82e-06	1.6e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.71e-06	1.5e-05	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AKT1—pancreatic cancer	1.64e-06	1.44e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—PIK3CA—pancreatic cancer	1.56e-06	1.37e-05	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AKT1—pancreatic cancer	1.5e-06	1.32e-05	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AKT1—pancreatic cancer	1.49e-06	1.31e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AKT1—pancreatic cancer	1.27e-06	1.12e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	1.2e-06	1.06e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AKT1—pancreatic cancer	9.83e-07	8.64e-06	CbGpPWpGaD
